PDB Short entry for 1A14 HEADER COMPLEX (ANTIBODY/ANTIGEN) 21-DEC-97 1A14 TITLE COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN TITLE 2 ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE CAVEAT 1A14 NAG N 477A HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURAMINIDASE; COMPND 3 CHAIN: N; COMPND 4 FRAGMENT: RESIDUES 82 - 468; COMPND 5 EC: 3.2.1.18; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NC10 FV (HEAVY CHAIN); COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: VH DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY COMPND 10 JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: NC10 FV (LIGHT CHAIN); COMPND 14 CHAIN: L; COMPND 15 FRAGMENT: VL DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY COMPND 16 JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 11320; SOURCE 4 STRAIN: N9, A/TERN/AUSTRALIA/G70C/75; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 7 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 14 ORGANISM_TAXID: 10090; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX (ANTIBODY-ANTIGEN), SINGLE-CHAIN ANTIBODY, GLYCOSYLATED KEYWDS 2 PROTEIN, COMPLEX (ANTIBODY-ANTIGEN) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.L.MALBY,A.J.MCCOY,A.A.KORTT,P.J.HUDSON,P.M.COLMAN REVDAT 6 02-AUG-23 1A14 1 REMARK HETSYN REVDAT 5 29-JUL-20 1A14 1 CAVEAT COMPND REMARK HET REVDAT 5 2 1 HETNAM FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 13-JUL-11 1A14 1 VERSN REVDAT 3 24-FEB-09 1A14 1 VERSN REVDAT 2 01-APR-03 1A14 1 JRNL REVDAT 1 13-MAY-98 1A14 0 JRNL AUTH R.L.MALBY,A.J.MCCOY,A.A.KORTT,P.J.HUDSON,P.M.COLMAN JRNL TITL THREE-DIMENSIONAL STRUCTURES OF SINGLE-CHAIN JRNL TITL 2 FV-NEURAMINIDASE COMPLEXES. JRNL REF J.MOL.BIOL. V. 279 901 1998 JRNL REFN ISSN 0022-2836 JRNL PMID 9642070 JRNL DOI 10.1006/JMBI.1998.1794 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.L.MALBY,J.B.CALDWELL,L.C.GRUEN,V.R.HARLEY,N.IVANCIC, REMARK 1 AUTH 2 A.A.KORTT,G.G.LILLEY,B.E.POWER,R.G.WEBSTER,P.M.COLMAN, REMARK 1 AUTH 3 P.J.HUDSON REMARK 1 TITL RECOMBINANT ANTINEURAMINIDASE SINGLE CHAIN ANTIBODY: REMARK 1 TITL 2 EXPRESSION, CHARACTERIZATION, AND CRYSTALLIZATION IN COMPLEX REMARK 1 TITL 3 WITH ANTIGEN REMARK 1 REF PROTEINS V. 16 57 1993 REMARK 1 REFN ISSN 0887-3585 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.0 REMARK 3 NUMBER OF REFLECTIONS : 27957 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : A POSTERIORI REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4800 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 112 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM1.CHO REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH1.CHO REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A14 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170262. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-95 REMARK 200 TEMPERATURE (KELVIN) : 283 REMARK 200 PH : 6.6-6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-18B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : PHOTON FACTORY REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROTEIN, WEIS REMARK 200 DATA SCALING SOFTWARE : PROTEIN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29660 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 68.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 40.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PDB ENTRY 1NMC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NC10 SCFV(5) AND N9 NA WERE MIXED REMARK 280 TOGETHER (SCFV(5) IN FOUR-FOLD MOLAR EXCESS) WITH AND EQUAL REMARK 280 VOLUME OF POTASSIUM PHOSPHATE BUFFER 1.7M PH6.6. THE DROP WAS REMARK 280 EQUILIBRATED BY VAPOR DIFFUSION AGAINST PHOSPHATE BUFFER 1.3M REMARK 280 PH6.8., VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 11555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 12555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 13555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 14555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 15555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 82.65000 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 91.20000 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 82.65000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 91.20000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 82.65000 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 91.20000 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 82.65000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 91.20000 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 82.65000 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 91.20000 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 82.65000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 91.20000 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 82.65000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 91.20000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 82.65000 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 82.65000 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 91.20000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: N, H, L, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 165.30000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 165.30000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 -1.000000 0.000000 0.000000 165.30000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 165.30000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG N 304 CD NE CZ NH1 NH2 REMARK 480 LYS N 435 CD CE NZ REMARK 480 GLN H 1 CB CG CD OE1 NE2 REMARK 480 GLN H 3 C CG CD OE1 NE2 REMARK 480 GLN H 5 C O CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN N 86 O5 NAG N 477A 2.12 REMARK 500 O4 NAG A 1 O5 NAG A 2 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG N 189 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG N 189 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 PRO N 267 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 PRO N 342 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 PRO H 52A C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE N 84 126.63 -36.55 REMARK 500 LEU N 87 88.25 -65.90 REMARK 500 SER N 96 -164.37 -162.69 REMARK 500 TYR N 100 -55.21 -120.43 REMARK 500 TYR N 121 160.60 179.64 REMARK 500 THR N 148 8.71 -54.81 REMARK 500 THR N 188 -152.23 -139.76 REMARK 500 ASN N 200 29.51 -158.87 REMARK 500 ILE N 222 78.79 42.91 REMARK 500 THR N 225 -154.57 -116.30 REMARK 500 GLU N 277 73.87 42.69 REMARK 500 CYS N 291 -157.69 -107.79 REMARK 500 TRP N 295 -76.01 -52.47 REMARK 500 ASN N 346 45.40 37.45 REMARK 500 TYR N 374 117.56 -166.82 REMARK 500 VAL N 379 79.16 -116.81 REMARK 500 SER N 404 -126.01 -119.30 REMARK 500 TYR N 412A 4.13 -69.09 REMARK 500 ALA H 16 -158.64 -71.28 REMARK 500 SER H 17 102.32 -164.48 REMARK 500 SER H 25 142.81 -175.72 REMARK 500 PRO H 41 99.21 -65.71 REMARK 500 LEU H 82C 155.94 -46.66 REMARK 500 ALA H 88 -176.05 179.24 REMARK 500 SER H 98 -113.57 50.88 REMARK 500 TYR H 100A 34.36 -97.87 REMARK 500 THR L 8 87.28 75.60 REMARK 500 ASP L 28 97.78 -55.11 REMARK 500 ASP L 41 40.10 -95.64 REMARK 500 TYR L 50 61.07 68.41 REMARK 500 THR L 51 -63.41 62.71 REMARK 500 SER L 60 -19.19 -49.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR N 341 0.07 SIDE CHAIN REMARK 500 TYR N 374 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE THREE OLIGOSACCHARIDES COVALENTLY ATTACHED TO N9 REMARK 600 NEURAMINIDASE ARE NUMBERED BY THE ASN RESIDUE TO WHICH THEY REMARK 600 ARE ATTACHED. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN N 475G REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA N 478 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP N 293 O REMARK 620 2 GLY N 297 O 65.4 REMARK 620 3 ASP N 324 OD2 69.8 75.3 REMARK 620 4 ASN N 347 O 99.9 157.3 83.5 REMARK 620 N 1 2 3 DBREF 1A14 N 82 468 UNP P03472 NRAM_IATRA 83 470 DBREF 1A14 H 1 111 GB 501094 AAA19165 23 142 DBREF 1A14 L 1 102 GB 501094 AAA19165 159 260 SEQRES 1 N 388 ARG ASP PHE ASN ASN LEU THR LYS GLY LEU CYS THR ILE SEQRES 2 N 388 ASN SER TRP HIS ILE TYR GLY LYS ASP ASN ALA VAL ARG SEQRES 3 N 388 ILE GLY GLU ASP SER ASP VAL LEU VAL THR ARG GLU PRO SEQRES 4 N 388 TYR VAL SER CYS ASP PRO ASP GLU CYS ARG PHE TYR ALA SEQRES 5 N 388 LEU SER GLN GLY THR THR ILE ARG GLY LYS HIS SER ASN SEQRES 6 N 388 GLY THR ILE HIS ASP ARG SER GLN TYR ARG ALA LEU ILE SEQRES 7 N 388 SER TRP PRO LEU SER SER PRO PRO THR VAL TYR ASN SER SEQRES 8 N 388 ARG VAL GLU CYS ILE GLY TRP SER SER THR SER CYS HIS SEQRES 9 N 388 ASP GLY LYS THR ARG MET SER ILE CYS ILE SER GLY PRO SEQRES 10 N 388 ASN ASN ASN ALA SER ALA VAL ILE TRP TYR ASN ARG ARG SEQRES 11 N 388 PRO VAL THR GLU ILE ASN THR TRP ALA ARG ASN ILE LEU SEQRES 12 N 388 ARG THR GLN GLU SER GLU CYS VAL CYS HIS ASN GLY VAL SEQRES 13 N 388 CYS PRO VAL VAL PHE THR ASP GLY SER ALA THR GLY PRO SEQRES 14 N 388 ALA GLU THR ARG ILE TYR TYR PHE LYS GLU GLY LYS ILE SEQRES 15 N 388 LEU LYS TRP GLU PRO LEU ALA GLY THR ALA LYS HIS ILE SEQRES 16 N 388 GLU GLU CYS SER CYS TYR GLY GLU ARG ALA GLU ILE THR SEQRES 17 N 388 CYS THR CYS ARG ASP ASN TRP GLN GLY SER ASN ARG PRO SEQRES 18 N 388 VAL ILE ARG ILE ASP PRO VAL ALA MET THR HIS THR SER SEQRES 19 N 388 GLN TYR ILE CYS SER PRO VAL LEU THR ASP ASN PRO ARG SEQRES 20 N 388 PRO ASN ASP PRO THR VAL GLY LYS CYS ASN ASP PRO TYR SEQRES 21 N 388 PRO GLY ASN ASN ASN ASN GLY VAL LYS GLY PHE SER TYR SEQRES 22 N 388 LEU ASP GLY VAL ASN THR TRP LEU GLY ARG THR ILE SER SEQRES 23 N 388 ILE ALA SER ARG SER GLY TYR GLU MET LEU LYS VAL PRO SEQRES 24 N 388 ASN ALA LEU THR ASP ASP LYS SER LYS PRO THR GLN GLY SEQRES 25 N 388 GLN THR ILE VAL LEU ASN THR ASP TRP SER GLY TYR SER SEQRES 26 N 388 GLY SER PHE MET ASP TYR TRP ALA GLU GLY GLU CYS TYR SEQRES 27 N 388 ARG ALA CYS PHE TYR VAL GLU LEU ILE ARG GLY ARG PRO SEQRES 28 N 388 LYS GLU ASP LYS VAL TRP TRP THR SER ASN SER ILE VAL SEQRES 29 N 388 SER MET CYS SER SER THR GLU PHE LEU GLY GLN TRP ASP SEQRES 30 N 388 TRP PRO ASP GLY ALA LYS ILE GLU TYR PHE LEU SEQRES 1 H 120 GLN VAL GLN LEU GLN GLN SER GLY ALA GLU LEU VAL LYS SEQRES 2 H 120 PRO GLY ALA SER VAL ARG MET SER CYS LYS ALA SER GLY SEQRES 3 H 120 TYR THR PHE THR ASN TYR ASN MET TYR TRP VAL LYS GLN SEQRES 4 H 120 SER PRO GLY GLN GLY LEU GLU TRP ILE GLY ILE PHE TYR SEQRES 5 H 120 PRO GLY ASN GLY ASP THR SER TYR ASN GLN LYS PHE LYS SEQRES 6 H 120 ASP LYS ALA THR LEU THR ALA ASP LYS SER SER ASN THR SEQRES 7 H 120 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 120 ALA VAL TYR TYR CYS ALA ARG SER GLY GLY SER TYR ARG SEQRES 9 H 120 TYR ASP GLY GLY PHE ASP TYR TRP GLY GLN GLY THR THR SEQRES 10 H 120 VAL THR VAL SEQRES 1 L 104 ASP ILE GLU LEU THR GLN THR THR SER SER LEU SER ALA SEQRES 2 L 104 SER LEU GLY ASP ARG VAL THR ILE SER CYS ARG ALA SER SEQRES 3 L 104 GLN ASP ILE SER ASN TYR LEU ASN TRP TYR GLN GLN ASN SEQRES 4 L 104 PRO ASP GLY THR VAL LYS LEU LEU ILE TYR TYR THR SER SEQRES 5 L 104 ASN LEU HIS SER GLU VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 104 GLY SER GLY THR ASP TYR SER LEU THR ILE SER ASN LEU SEQRES 7 L 104 GLU GLN GLU ASP ILE ALA THR TYR PHE CYS GLN GLN ASP SEQRES 8 L 104 PHE THR LEU PRO PHE THR PHE GLY GLY GLY THR ALA ALA MODRES 1A14 ASN N 200 ASN GLYCOSYLATION SITE MODRES 1A14 ASN N 146 ASN GLYCOSYLATION SITE MODRES 1A14 ASN N 86 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET BMA A 3 11 HET MAN A 4 11 HET MAN A 5 11 HET MAN A 6 11 HET MAN N 475G 11 HET NAG N 476A 14 HET NAG N 477A 14 HET CA N 478 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM CA CALCIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 4 NAG 4(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 4 MAN 4(C6 H12 O6) FORMUL 8 CA CA 2+ HELIX 1 1 ALA N 105 GLU N 110 1 6 HELIX 2 2 ILE N 464 TYR N 466 5 3 HELIX 3 3 PHE H 29 ASN H 31 5 3 HELIX 4 4 GLN H 61 PHE H 63 5 3 HELIX 5 5 SER H 84 ASP H 86 5 3 HELIX 6 6 GLN L 80 ASP L 82 5 3 SHEET 1 A 4 TYR N 121 CYS N 124 0 SHEET 2 A 4 CYS N 129 SER N 135 -1 N TYR N 132 O TYR N 121 SHEET 3 A 4 ALA N 157 PRO N 162 -1 N TRP N 161 O PHE N 131 SHEET 4 A 4 ARG N 172 ILE N 176 -1 N CYS N 175 O LEU N 158 SHEET 1 B 4 SER N 179 HIS N 184 0 SHEET 2 B 4 ARG N 189 SER N 195 -1 N ILE N 194 O SER N 179 SHEET 3 B 4 SER N 202 TYR N 207 -1 N TRP N 206 O SER N 191 SHEET 4 B 4 PRO N 211 ASN N 216 -1 N ILE N 215 O ALA N 203 SHEET 1 C 4 VAL N 231 HIS N 233 0 SHEET 2 C 4 VAL N 236 ASP N 243 -1 N PRO N 238 O VAL N 231 SHEET 3 C 4 GLU N 251 LYS N 258 -1 N PHE N 257 O CYS N 237 SHEET 4 C 4 LYS N 261 PRO N 267 -1 N GLU N 266 O ILE N 254 SHEET 1 D 4 SER N 279 GLU N 283 0 SHEET 2 D 4 GLU N 286 THR N 290 -1 N THR N 290 O SER N 279 SHEET 3 D 4 PRO N 301 ASP N 306 -1 N ILE N 305 O ILE N 287 SHEET 4 D 4 THR N 311 TYR N 316 -1 N GLN N 315 O VAL N 302 SHEET 1 E 3 TRP N 361 ARG N 364 0 SHEET 2 E 3 TYR N 374 LYS N 378 -1 N LEU N 377 O LEU N 362 SHEET 3 E 3 GLN N 392 VAL N 398 -1 N VAL N 398 O TYR N 374 SHEET 1 F 4 SER N 407 MET N 411 0 SHEET 2 F 4 ALA N 420 GLY N 429 -1 N TYR N 423 O GLY N 408 SHEET 3 F 4 THR N 439 SER N 449 -1 N MET N 446 O PHE N 422 SHEET 4 F 4 SER N 96 LYS N 102 -1 N GLY N 101 O SER N 445 SHEET 1 G 4 GLN H 3 GLN H 6 0 SHEET 2 G 4 ARG H 19 SER H 25 -1 N SER H 25 O GLN H 3 SHEET 3 G 4 THR H 77 LEU H 82 -1 N MET H 80 O MET H 20 SHEET 4 G 4 ALA H 67 ASP H 72 -1 N ASP H 72 O THR H 77 SHEET 1 H 5 ASP H 56 TYR H 59 0 SHEET 2 H 5 GLY H 44 TYR H 52 -1 N TYR H 52 O ASP H 56 SHEET 3 H 5 ASN H 33 SER H 40 -1 N SER H 40 O GLY H 44 SHEET 4 H 5 VAL H 89 SER H 95 -1 N ALA H 93 O TYR H 35 SHEET 5 H 5 PHE H 100E TRP H 103 -1 N TYR H 102 O ARG H 94 SHEET 1 I 4 LEU L 4 THR L 7 0 SHEET 2 I 4 VAL L 19 ALA L 25 -1 N ARG L 24 O THR L 5 SHEET 3 I 4 ASP L 70 ILE L 75 -1 N ILE L 75 O VAL L 19 SHEET 4 I 4 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 J 4 THR L 102 ALA L 104 0 SHEET 2 J 4 ALA L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 3 J 4 LEU L 33 GLN L 38 -1 N GLN L 38 O THR L 85 SHEET 4 J 4 VAL L 44 TYR L 49 -1 N ILE L 48 O TRP L 35 SSBOND 1 CYS N 92 CYS N 417 1555 1555 2.03 SSBOND 2 CYS N 124 CYS N 129 1555 1555 2.01 SSBOND 3 CYS N 175 CYS N 193 1555 1555 2.02 SSBOND 4 CYS N 183 CYS N 230 1555 1555 2.05 SSBOND 5 CYS N 232 CYS N 237 1555 1555 2.04 SSBOND 6 CYS N 278 CYS N 291 1555 1555 2.01 SSBOND 7 CYS N 280 CYS N 289 1555 1555 2.01 SSBOND 8 CYS N 318 CYS N 337 1555 1555 2.03 SSBOND 9 CYS N 421 CYS N 447 1555 1555 2.03 SSBOND 10 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 11 CYS L 23 CYS L 88 1555 1555 2.02 LINK ND2 ASN N 86 C1 NAG N 477A 1555 1555 1.54 LINK ND2 ASN N 146 C1 NAG N 476A 1555 1555 1.45 LINK ND2 ASN N 200 C1 NAG A 1 1555 1555 1.46 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.33 LINK O4 NAG A 2 C1 BMA A 3 1555 1555 1.40 LINK O3 BMA A 3 C1 MAN A 4 1555 1555 1.39 LINK O2 MAN A 4 C1 MAN A 5 1555 1555 1.40 LINK O2 MAN A 5 C1 MAN A 6 1555 1555 1.39 LINK O ASP N 293 CA CA N 478 1555 1555 3.06 LINK O GLY N 297 CA CA N 478 1555 1555 2.58 LINK OD2 ASP N 324 CA CA N 478 1555 1555 3.40 LINK O ASN N 347 CA CA N 478 1555 1555 2.85 CISPEP 1 ASN N 325 PRO N 326 0 0.64 CISPEP 2 ARG N 430 PRO N 431 0 -0.53 CISPEP 3 LEU L 94 PRO L 95 0 0.66 CRYST1 165.300 165.300 182.400 90.00 90.00 90.00 I 4 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006050 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006050 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005482 0.00000